- drug was
created and
initially developed by
BioVex, Inc. and was
continued by Amgen,
which acquired BioVex in 2011. It was one of the
first oncolytic immunotherapy...
-
manufacturing facility near Dublin, Ireland, in March. In May,
Amgen acquired BioVex,
developer of
Imlygic (talimogene laherparepvec). In December,
Amgen and...
-
likely been discontinued. A
private company called BioVex began Phase I
clinical trials for Immuno
VEX,
another proposed vaccine, in
March 2010. The company...
- drug was
created and
initially developed by
BioVex, Inc. and was
continued by Amgen,
which acquired BioVex in 2011. It was the
first oncolytic virus approved...
-
oncolytic virus also
known as 'Onco
VEX GM-CSF'. It was
developed by
BioVex Inc. (Woburn, MA, USA & Oxford, UK)
until BioVex was
purchased by
Amgen in January...
- him to
establish the
robotics company Complex Matters. In
January 2011,
BioVex, a
cancer vaccines company spun-out of UCL in 1999, was sold to
Amgen for...
- to
reverse the
effects of
neurological diseases. In 1998,
Evans founded Biovex, a
company which specialised in the
development of a
genetically modified...
-
melanoma cancer vaccines such as Vical’s Allovectin-7 (11% CR + PR) and
BioVex’s Onco
Vex (28% CR + PR), both of
which are
given as
stand alone therapy. Due...
-
Sickness Sovereign (2009)
Sigil ****
Christ (2012) "Darkness
Dealer (2003)
Vexing Verses"" (2009)
Merrimack ex-live
vocalist Loudblast author of Hazardous...
- be very
effective in
eliminating tumours, most
notably so far Onco
VEX GM-CSF (
BioVex Inc, Woburn, MA)
which is in
Phase 3
clinical trials for melanoma...
